Some researchers have reported growth inhibitory effects of metformin against MTC cell lines (TT and MZ-CRC-1), which were attributable to the downregulation of both mTOR/6SK and pERK signaling. Here, EIF2AK3 is linked to medullary thyroid gland carcinoma.